Overview of hormonal therapy for prostate cancer.
Carter
H B
HB
Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
Isaacs
J T
JT
D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002455:Cell Division; D002470:Cell Survival; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy
D000726:Androgen Antagonists; D000970:Antineoplastic Agents